200 related articles for article (PubMed ID: 9301594)
1. Epstein-Barr virus. A serial killer or an innocent bystander?
Sangüeza OP
Arch Dermatol; 1997 Sep; 133(9):1156-7. PubMed ID: 9301594
[No Abstract] [Full Text] [Related]
2. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
[No Abstract] [Full Text] [Related]
3. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
Hidalgo M; Lumbreras C; Aguado JM
Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
[No Abstract] [Full Text] [Related]
4. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
[No Abstract] [Full Text] [Related]
5. Post-transplant lymphoproliferative disorder.
Basgoz N; Preiksaitis JK
Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis.
Imashuku S; Naya M; Yamori M; Nakabayashi Y; Hojo M; Kihara A; Tabata Y; Akioka C; Hibi S; Todo S
Bone Marrow Transplant; 1997 May; 19(10):1059-60. PubMed ID: 9169655
[No Abstract] [Full Text] [Related]
7. [Epstein-Barr virus infection: immunology and immunopathology].
Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
[No Abstract] [Full Text] [Related]
8. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
Transplantation; 1995 Feb; 59(4):637-40. PubMed ID: 7533350
[No Abstract] [Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and lymphoproliferative disorders.
Sullivan JL
Semin Hematol; 1988 Jul; 25(3):269-79. PubMed ID: 2841766
[No Abstract] [Full Text] [Related]
11. Overview of posttransplant B-cell lymphoproliferative disorders.
Swinnen LJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and bone marrow transplantation.
Caldas C; Ambinder R
Curr Opin Oncol; 1995 Mar; 7(2):102-6. PubMed ID: 7756374
[TBL] [Abstract][Full Text] [Related]
13. Isolated central nervous system Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
Watanabe A; Yoshida S; Kasahara Y; Takachi T; Ogawa A; Asami K
Pediatr Blood Cancer; 2011 May; 56(5):871-2. PubMed ID: 21370426
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus--associated posttransplant lymphoproliferative disorder presenting as perirenal transplant lymphocele.
Squiers EC; West JC; Leonard D; Latsha R; Miller J; Fetterolf N; Kelley SE; Tyler W
Transplantation; 1993 Nov; 56(5):1278-9. PubMed ID: 8249138
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus (EBV)-associated hepatic and splenic smooth muscle tumours after kidney transplantation.
Morel D; Merville P; Le Bail B; Berger F; Saric J; Potaux L
Nephrol Dial Transplant; 1996 Sep; 11(9):1864-6. PubMed ID: 8918643
[No Abstract] [Full Text] [Related]
16. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
Purtilo DT
Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
[No Abstract] [Full Text] [Related]
17. Fatal case of Epstein-Barr virus-induced lymphoproliferative disorder associated with a human immunodeficiency virus infection.
Beissner RS; Rappaport ES; Diaz JA
Arch Pathol Lab Med; 1987 Mar; 111(3):250-3. PubMed ID: 3030225
[TBL] [Abstract][Full Text] [Related]
18. Hematologic consequences of Epstein-Barr virus infection.
Sullivan JL
Hematol Oncol Clin North Am; 1987 Sep; 1(3):397-417. PubMed ID: 2834314
[TBL] [Abstract][Full Text] [Related]
19. Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals.
Purtilo DT; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4209. PubMed ID: 6272963
[No Abstract] [Full Text] [Related]
20. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
Klein G; Purtilo D
Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
